Newsletter

Susceptibility Testing, Empowered - Newsletter

The newsletter is dedicated to exploring AST topics, brought to you by our in-house experts. We look at everything from topics in the news to emerging technology, pushing AST stewardship to the next level. A few featured articles are available to view below, or visit the full newsletter page to browse all articles and to subscribe:

Obtaining a definitive MIC result: Because you don’t know what you don’t know

Minimum inhibitory concentration (MIC) results can play an important role in fighting antimicrobial resistance (AMR) and in guiding optimal clinical decisions. It’s too important to fail, but there is still some uncertainty about the best way to generate results. So, when does true mean true, what is a “definitive” MIC, and how does it provide the best path to right-first-time decisions?

Infection Management Coalition white paper: tackling AMR requires transformational change

Apply the learnings of COVID to AMR, says coalition. Tackling the deadly spectre of antimicrobial resistance (AMR) requires urgent, transformational, whole-system change. In this white paper, The Infection Management Coalition (IMC) claims that now is the time for the healthcare ecosystem to unite against the “existential threat” of resistance.

Balancing the dangers of sepsis and antimicrobial resistance

In recent years, awareness campaigns and policy decisions have contributed to a “better safe than sorry” approach to treating sepsis. However, such models mean patients may receive unnecessary antibiotics – a trend that can act as a contributing factor to the development of antimicrobial resistance (AMR).

Speak to a specialist

Availability of product in each country depends on local regulatory marketing authorization status.